Company intelligence / Profile preview

Memel Biotech

Klaipėda, Lithuania

Ownership: Private
Development stage: Other

Overview

Memel Biotech is a Lithuanian-based contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), including cell, gene, and tissue-engineered therapies. It offers comprehensive services from discovery through to commercial manufacturing, targeting partnerships with biotech companies seeking to enter the ATMP space. The company is currently undergoing bankruptcy proceedings as of early 2025.

Modalities: Cell therapyGene therapyTissue-engineered therapyStem cell therapy (mesenchymal stem cells, induced pluripotent stem cells)Immune cell therapy (natural killer cells, dendritic cells)CAR-T cell therapyExtracellular vesicle/exosome-based therapy
Industry: Contract Manufacturing Organization

Partnerships

THERABEST Korea (for precision medicine research)Cureline Group (strategic/investment relationship)various biotech SMEs focusing on cell and gene therapies

Beyond the preview

Go deeper on Memel Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memel Biotech.

Explore the full profile